risperidone has been researched along with Adenoma in 4 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hazard ratio of confirmed pituitary tumors with mass effect was 1." | 1.38 | Follow-up study of a pharmacovigilance signal: no evidence of increased risk with risperidone of pituitary tumor with mass effect. ( Jiang, R; McAfee, AT; McCarren, M; Qiu, H; Wang, Y; Ziyadeh, N, 2012) |
| " Preclinical evidence shows that chronic administration of antipsychotics can cause pituitary adenomas in female mice." | 1.34 | Atypical antipsychotics and pituitary neoplasms in the WHO database. ( Doraiswamy, PM; Edwards, R; Mueller-Oerlinghausen, B; Schott, G; Star, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, KW | 1 |
| Lee, J | 1 |
| Swapna, V | 1 |
| McCarren, M | 1 |
| Qiu, H | 1 |
| Ziyadeh, N | 1 |
| Jiang, R | 1 |
| Wang, Y | 1 |
| McAfee, AT | 1 |
| Molitch, ME | 1 |
| Doraiswamy, PM | 1 |
| Schott, G | 1 |
| Star, K | 1 |
| Edwards, R | 1 |
| Mueller-Oerlinghausen, B | 1 |
4 other studies available for risperidone and Adenoma
| Article | Year |
|---|---|
Management of a patient with schizophrenia and underlying pituitary macroadenoma.
Topics: Adenoma; Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bromocriptine; Dopamine Antagon | 2010 |
Follow-up study of a pharmacovigilance signal: no evidence of increased risk with risperidone of pituitary tumor with mass effect.
Topics: Adenoma; Adult; Aged; Case-Control Studies; Cohort Studies; Female; Follow-Up Studies; Humans; Longi | 2012 |
Atypical antipsychotics and pituitary tumors.
Topics: Adenoma; Female; Humans; Male; Pharmacovigilance; Pituitary Neoplasms; Risperidone | 2012 |
Atypical antipsychotics and pituitary neoplasms in the WHO database.
Topics: Adenoma; Adult; Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Causalit | 2007 |